Access Bio Inc Cash Flow Conversion Efficiency

Latest as of June 2025: -0.015x

Access Bio Inc cash flow conversion efficiency. Based on the latest financial reports, Access Bio Inc (950130) has a cash flow conversion efficiency ratio of -0.015x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-9.16 Billion ≈ $-6.21 Million USD) by net assets (₩599.93 Billion ≈ $406.56 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Access Bio Inc (2012–2024)

Cash flow conversion efficiency of Access Bio Inc from 2012 to 2024. This chart illustrates how Access Bio Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Access Bio Inc stock price for real-time trading data and today's change.

Access Bio Inc Cash Flow Conversion Ratio Explained

Access Bio Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Access Bio Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Access Bio Inc ranked by their cash flow conversion efficiency. Also see 950130 stock market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
KENERGY KLSE:0307	-0.049x
Senko Co. Ltd KQ:347000	0.022x
Silvano Fashion Group AS WAR:SFG	0.016x
Plastiblends India Limited NSE:PLASTIBLEN	-0.001x
Impact BioMedical, Inc. NYSE MKT:IBO	0.225x
Verbrec Ltd AU:VBC	0.060x
Public Packages Holdings Bhd KLSE:8273	0.018x
Enwell Energy plc F:RHN	-0.003x

Annual Cash Flow Conversion Efficiency for Access Bio Inc (2012–2024)

The table below shows the annual cash flow conversion efficiency of Access Bio Inc from 2012 to 2024. Review 950130 free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩442.28 Million ≈ $299.73K	₩13.54 Million ≈ $9.18K	0.031x	+22410.95%
2023-12-31	₩587.14 Billion ≈ $397.90 Million	₩-80.57 Million ≈ $-54.60K	0.000x	-100.02%
2022-12-31	₩487.74 Million ≈ $330.53K	₩291.33 Million ≈ $197.43K	0.597x	+4.71%
2021-12-31	₩241.75 Million ≈ $163.83K	₩137.90 Million ≈ $93.45K	0.570x	-99.88%
2020-12-31	₩76.95 Million ≈ $52.15K	₩36.72 Billion ≈ $24.89 Million	477.222x	+2498.24%
2019-12-31	₩21.22 Million ≈ $14.38K	₩-422.24 Million ≈ $-286.15K	-19.899x	+88.40%
2018-12-31	₩33.42 Million ≈ $22.65K	₩-5.73 Billion ≈ $-3.88 Million	-171.471x	-29.50%
2017-12-31	₩41.13 Million ≈ $27.87K	₩-5.45 Billion ≈ $-3.69 Million	-132.408x	-298039.61%
2016-12-31	₩47.55 Million ≈ $32.22K	₩2.11 Million ≈ $1.43K	0.044x	+19.26%
2015-12-31	₩76.88 Billion ≈ $52.10 Million	₩2.87 Billion ≈ $1.94 Million	0.037x	+197.03%
2014-12-31	₩68.58 Billion ≈ $46.48 Million	₩-2.63 Billion ≈ $-1.79 Million	-0.038x	-221.48%
2013-12-31	₩50.20 Billion ≈ $34.02 Million	₩1.59 Billion ≈ $1.08 Million	0.032x	-62.82%
2012-12-31	₩21.71 Billion ≈ $14.71 Million	₩1.85 Billion ≈ $1.25 Million	0.085x	--

About Access Bio Inc

KQ:950130 Korea Diagnostics & Research

Market Cap

$45.55 Million

₩67.22 Billion KRW

Market Cap Rank

#22080 Global

#1379 in Korea

Share Price

₩1911.00

Change (1 day)

-0.68%

52-Week Range

₩1911.00 - ₩2570.00

All Time High

₩29950.00